M6I (p.Met6Ile) variant of ATRX (Chromatin remodeler ATRX)
M6I (p.Met6Ile) in ATRX (Chromatin remodeler ATRX) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Alpha thalassemia-X-linked intellectual disability syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data, published literature, and structural context.
M6I (p.Met6Ile) variant details
- p.Met6Ile
- rs2076734106
- ClinGen CA413706567
- ClinVar RCV001062003
- TOPMed rs2076734106
- Uncertain significance
- Alpha thalassemia-X-linked intellectual disability syndrome
- Missense
- Variant Prioritization Score for Impact Estimate 0.364
- REVEL 0.39
- ESM-1b 0.00
- AlphaMissense 0.21
- CADD 21.60
- PolyPhen-2 0.10
- SIFT 0.38
- ClinVar: Uncertain significance (Alpha thalassemia-X-linked intellectual disability syndrome)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Population evidence available
- Structural context available
- Cited in: Alpha-Thalassemia X-Linked Intellectual Disability Syndrome. (PMID 20301622)